Search Results - "YAMAOKA, Masuo"

Refine Results
  1. 1

    Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer by YAMAOKA, Masuo, HARA, Takahito, KUSAKA, Masami

    Published in Clinical cancer research (01-09-2010)
    “…Prostate cancer is the most common form of cancer in males in the United States, and the second leading cause of cancer death. Initially, most cases of…”
    Get full text
    Journal Article
  2. 2

    Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile by Hikichi, Yukiko, Yamaoka, Masuo, Kusaka, Masami, Hara, Takahito

    Published in European journal of pharmacology (15-10-2015)
    “…Selective androgen receptor modulators (SARMs) specifically bind to the androgen receptor and exert agonistic or antagonistic effects on target organs. In this…”
    Get full text
    Journal Article
  3. 3

    Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f by Morimoto, Megumi, Amano, Yuichiro, Oka, Masahiro, Harada, Ayako, Fujita, Hisashi, Hikichi, Yukiko, Tozawa, Ryuichi, Yamaoka, Masuo, Hara, Takahito

    Published in PloS one (07-12-2017)
    “…Sarcopenia and cachexia present characteristic features of a decrease in skeletal muscle mass and strength, anorexia, and lack of motivation. Treatments for…”
    Get full text
    Journal Article
  4. 4

    A selective androgen receptor modulator SARM‐2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys by Morimoto, Megumi, Yamaoka, Masuo, Hara, Takahito

    Published in Pharmacology research & perspectives (01-02-2020)
    “…SARM‐2f a selective androgen receptor (AR) modulator, increases skeletal muscle mass and locomotor activity in rats. This study aimed to clarify its…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I by Aikawa, Katsuji, Miyawaki, Toshio, Hitaka, Takenori, Imai, Yumi N., Hara, Takahito, Miyazaki, Junichi, Yamaoka, Masuo, Kusaka, Masami, Kanzaki, Naoyuki, Tasaka, Akihiro, Shiraishi, Mitsuru, Yamamoto, Satoshi

    Published in Bioorganic & medicinal chemistry (15-05-2015)
    “…[Display omitted] To develop effective drugs for hypogonadism, sarcopenia, and cachexia, we designed, synthesized, and evaluated selective androgen receptor…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    C17,20-Lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors by MATSUNAGA, Nobuyuki, KAKU, Tomohiro, TASAKA, Akihiro, ITOH, Fumio, TANAKA, Toshimasa, HARA, Takahito, MIKI, Hiroshi, IWASAKI, Masahiko, AONO, Tetsuya, YAMAOKA, Masuo, KUSAKA, Masami

    Published in Bioorganic & medicinal chemistry (01-05-2004)
    “…Novel nonsteroidal C(17,20)-lyase inhibitors were synthesized using de novo design based on its substrate, 17 alpha-hydroxypregnenolone, and several compounds…”
    Get full text
    Journal Article
  10. 10

    Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models by Morimoto, Megumi, Aikawa, Katsuji, Hara, Takahito, Yamaoka, Masuo

    Published in Oncology letters (01-12-2017)
    “…Cancer cachexia is a syndrome that impairs the quality of life and overall survival of patients, and thus the effectiveness of anticancer agents. There are no…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats by Hara, Takahito, Kouno, Jin, Kaku, Tomohiro, Takeuchi, Toshiyuki, Kusaka, Masami, Tasaka, Akihiro, Yamaoka, Masuo

    “…► Orteronel specifically inhibited 17,20 lyase over 17-hydroxylase in a rat model. ► Inhibition by orteronel appeared reversible. ► Orteronel may therefore be…”
    Get full text
    Journal Article
  13. 13

    Novel mutations of androgen receptor: A possible mechanism of bicalutamide withdrawal syndrome by HARA, Takahito, MIYAZAKI, Jun-Ichi, ARAKI, Hideo, YAMAOKA, Masuo, KANZAKI, Naoyuki, KUSAKA, Masami, MIYAMOTO, Masaomi

    Published in Cancer research (Chicago, Ill.) (2003)
    “…Most prostate cancers (PCs) become resistant to combined androgen blockade therapy with surgical or medical castration and antiandrogens after several years…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists by Yamamoto, Satoshi, Kobayashi, Hiromi, Kaku, Tomohiro, Aikawa, Katsuji, Hara, Takahito, Yamaoka, Masuo, Kanzaki, Naoyuki, Hasuoka, Atsushi, Baba, Atsuo, Ito, Mitsuhiro

    Published in Bioorganic & medicinal chemistry (01-01-2013)
    “…A series of 3-aryl-3-hydroxy-1-phenylpyrrolidine compounds were designed, synthesized, and evaluated for their potential as novel orally available androgen…”
    Get full text
    Journal Article
  18. 18

    17,20-Lyase inhibitors. Part 4: Design, synthesis and structure–activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors by Kaku, Tomohiro, Matsunaga, Nobuyuki, Ojida, Akio, Tanaka, Toshimasa, Hara, Takahito, Yamaoka, Masuo, Kusaka, Masami, Tasaka, Akihiro

    Published in Bioorganic & medicinal chemistry (01-03-2011)
    “…A novel series of naphthylmethylimidazole derivatives and related compounds have been investigated as selective 17,20-lyase inhibitors. A novel series of…”
    Get full text
    Journal Article
  19. 19

    17,20-Lyase inhibitors. Part 3: Design, synthesis, and structure–activity relationships of biphenylylmethylimidazole derivatives as novel 17,20-lyase inhibitors by Kaku, Tomohiro, Tsujimoto, Saori, Matsunaga, Nobuyuki, Tanaka, Toshimasa, Hara, Takahito, Yamaoka, Masuo, Kusaka, Masami, Tasaka, Akihiro

    Published in Bioorganic & medicinal chemistry (01-04-2011)
    “…A novel series of biphenylylmethylimidazole derivatives were synthesized as inhibitors of 17,20-lyase, and their biological activities were evaluated. A novel…”
    Get full text
    Journal Article
  20. 20

    A mutation in β-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line by Hara, Takahito, Ushio, Kazutaka, Nishiwaki, Mayumi, Kouno, Jin, Araki, Hideo, Hikichi, Yukiko, Hattori, Masahiko, Imai, Yumi, Yamaoka, Masuo

    Published in Cell biology international (01-02-2010)
    “…The mechanisms of docetaxel resistance in PC (prostate cancer) are unclear because of the lack of suitable experimental models, and no effective treatment…”
    Get full text
    Journal Article